基本信息
分子量221
阿法埃莎
5-氨基-3-溴-1-甲基吲唑, 3-bromo-1-methyl-1H-indazol-5-amine
(1S,2S,5R)-3-叔丁基2-甲基6,6-二甲基-3-氮杂双环[3.1.0]己烷-2,3-二羧酸酯, (1S,2S,5R)-3-tert-butyl 2-methyl 6,6-dimethyl-3-azabicyclo[3
(4S,5S)-2-(((4S,5S)-1,3-二甲基-4,5-二苯基咪唑烷-2-亚基)氨基)-1,3-二甲基-4,5-二苯基-4, (4S,5S)-2-(((4S,5S)-1,3-dimethyl-4,5-diphenylimidazolidin-2-
1-(4-(甲基硫)苯基)哌嗪, 1-(4-(Methylthio)phenyl)piperazine
(S)-3-(((9H-芴-9-基)甲氧基)羰基)噻唑烷-4-羧酸, (S)-3-(((9H-Fluoren-9-yl)methoxy)carbonyl)thiazolidine-4-car
(S)-2-((5-苯基-1,3,4-噁二唑-2-基)甲基)吡咯烷-1-甲酸叔丁酯, (S)-tert-butyl 2-((5-phenyl-1,3,4-oxadiazol-2-yl)methyl)pyrr
叔丁基4-(7-(2-(环丙基甲氧基)-6-((4-甲氧基苄基)氧基)苯基)-2-氧代-2,4-二氢-1H-吡啶并[2,3-d] [11,3]噁嗪-5-基)哌啶-1-羧酸叔丁酯, tert-butyl 4-(7-(2-(cyclopropylmethoxy)-6-((4-methoxybenzyl)
(3-碘-1H-吡唑并[3,4-d]嘧啶-4-基)氨基双甲酸叔丁酯, Imidodicarbonic acid
N-甲基-2-硝基苯磺酰胺, N-Methyl-2-nitrobenzenesulfonamide
2-(咪唑-2-基)吡啶, 2-(Pyridyl-2-yl)imidazole